Xigduo XR Prices, Coupons, Copay Cards & Patient Assistance
Xigduo XR (dapagliflozin/metformin) is a member of the antidiabetic combinations drug class and is commonly used for Heart Failure, and Type 2 Diabetes.
The cost for Xigduo XR (10 mg-500 mg) oral tablet, extended release is around $635 for a supply of 30 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
A generic version of Xigduo XR is available. See dapagliflozin/metformin prices.
Xigduo XR prices
Oral Tablet, Extended Release
10 mg-500 mg
Xigduo XR oral tablet, extended release
from $635.35
for 30 tablets
Quantity | Per unit | Price |
---|---|---|
30 | $21.18 | $635.35 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
5 mg-500 mg
Xigduo XR oral tablet, extended release
from $635.35
for 30 tablets
Quantity | Per unit | Price |
---|---|---|
30 | $21.18 | $635.35 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
10 mg-1000 mg
Xigduo XR oral tablet, extended release
from $635.35
for 30 tablets
Quantity | Per unit | Price |
---|---|---|
30 | $21.18 | $635.35 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
2.5 mg-1000 mg
Xigduo XR oral tablet, extended release
from $635.35
for 60 tablets
Quantity | Per unit | Price |
---|---|---|
60 | $10.59 | $635.35 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
5 mg-1000 mg
Xigduo XR oral tablet, extended release
from $635.35
for 60 tablets
Quantity | Per unit | Price |
---|---|---|
60 | $10.59 | $635.35 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Xigduo XR Coupons, Copay Cards and Rebates
Xigduo XR offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
No manufacturer promotions could be found for this medication.
Patient Assistance & Copay Programs for Xigduo XR
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: AZ&Me Prescription Savings Program for people without insurance
Eligibility requirements:- Must have no prescription coverage for needed medication
- Varies
- Not required
- The patient must also be a US resident.
- People who are in Medicare and may be eligible for the Limited Income Subsidy can apply. However, if they are accepted into the LIS, they are no longer eligible for the AZ& Me Prescription Savings Program. Eligibility determined on a case-by-case basis.
- Xigduo XR (dapagliflozin propanediol/metformin) Tablet; Extended-Release
More information please phone: 800-292-6363 Visit Website
Provider: AZ&Me Prescription Savings Program for people with Medicare Part D
Eligibility requirements:- Contact program for details.
- Varies
- Not required
- The patient must also be a US resident.
- Eligibility determined on a case-by-case basis. *Patient must participate in Medicare Part B, Medicare Part D or Medicare Advantage This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Xigduo XR (dapagliflozin propanediol/metformin) Tablet; Extended-Release
More information please phone: 800-292-6363 Visit Website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Xigduo XR (dapagliflozin-metformin) Tablet; Extended-Release
More information please phone: 866-316-7263 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Xigduo XR (dapagliflozin / metformin)
- Check interactions
- Compare alternatives
- Reviews (17)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
- En español